BioCentury
ARTICLE | Company News

Dovetail, University of Maryland deal

December 18, 2000 8:00 AM UTC

Dovetail acquired an exclusive worldwide license from the university to technology for the design and manufacture of second generation recombinant DNA biopharmaceuticals, and its IFN DT modified inter...